top of page
Search

The Role of Neuroinflammation in Various Neurological Diseases

Written by Jayla M. Jones, Edited by Oluwatofunmi Adojutelegan


Neuroinflammation: A Key Target for Novel Therapeutic Interventions

Studies relating to neuroinflammation have always determined it to be a result of prior neurological injury or neurological injury in general that is usually caused by direct damage from a physical impact. Conversely, neuroinflammation is now being further investigated and acknowledged as a main participant involved in the pathogenesis of a wide range of neurological disorders. Varying from conditions such as stroke and traumatic brain injury to Alzheimer's and Parkinson’s disease, deviant inflammatory responses inside the brain are presumed to worsen neuronal damage and increase the rate associated with the progression of diseases. It is crucial for the initial inflammatory operation to continue to serve its purpose, which is to protect the functionality of the system; otherwise, the system will become dysfunctional, leading to a continuous cycle of neurotoxicity according to https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-025-00801-8.pdf. In conclusion, this text emphasizes that neuroinflammation is now recognized as a key factor in the development and progression of various neurological disorders, rather than just a result of direct physical damage.  This shift in understanding of neuroinflammation's role makes it a significant target for novel therapeutic interventions.

A comprehensive in-depth explanation of neuroinflammation pathogenesis in neurological disorders.

Neuroinflammation is the inflammation of the nervous system (Adamu et al., 2024). It is a complex response including several glial cells (microglia, astrocytes), neurons, and immune meditators (cytokines, chemokines) inside the spinal cord and brain. Although acute neuroinflammation can be a neuroprotective factor, unsolved and severe neuroinflammation significantly promotes the development of several neurological disorders and worsens neuronal damage in accordance with https://www.americanbrainfoundation.org/what-is-neuroinflammation/#:~:text=Neuroinflammation%20is%20a%20crucial%20underlying,to%20age%2C%E2%80%9D%20explains%20Dr and  (Giri et al., 2024).   In conditions such as strokes and traumatic brain injury, neuroinflammation intensifies secondary brain impairment through the initiation of microglia and astrocytes, causing a release of potentially inflammatory cytokines. Diseases about the progressive loss of nerve cells such as Alzheimer's and Parkison, and severe neuroinflammation contribute to neuronal dysfunction and loss, contributing to a decline in cognitive function and deficiency in motor skills (Singh K. et al., 2024). Key therapeutic approaches concentrate on reducing microglial initiation to reduce inflammation and neurons, modulating cytokine generation to recover tissue in the brain, and preserving the integrity of blood-brain barrier to prevent inflammatory molecules from entering the brain, along with applying the regulation of immune functions to enhance patients outcomes. 


Brief discussion

The therapeutic approaches discussed involve the reduction of microglial activation, modulation of cytokine generation, perseverance of the blood-brain barrier, and regulation of immune functions. All these approaches serve as idealistic strategies for intervention. However, more advanced research will need to thoroughly explain the exact processes by which neuroinflammation contributes to diverse neurological disorders and to create targeted therapies that will efficiently modulate the inflammatory response without risking accidental side effects. A key limitation of the present understanding of neuroinflammation is the heterogeneity of neuroinflammation across different disease circumstances and stages. Future researchers should devote their attention to differentiating precise inflammatory signatures for different neurological disorders,  creating personalized therapies, and organizing prolonged studies to analyze long-term effects and determine ideal intervention timing (https://www.sciencedirect.com/science/article/pii/S1568163722000605) and (https://www.nature.com/articles/s41392-023-01588-0). 


Conclusion

In conclusion, this research paper emphasizes the adapting understanding of neuroinflammation, changing from being viewed solely as a result of neurological injury to a vital element in the development of numerous neurological disorders. It has been established that the diverse nature of neuroinflammation across each particular disorder requires more refined research. It has also been acknowledged that the correlation between neuroinflammation and microglial activation is far more complicated than usually portrayed (https://journals.lww.com/nrronline/fulltext/2025/07000/neuroinflammation_revisited_through_the_microglial.12.aspx). Future efforts should focus on recognizing distinctive inflammatory profiles for each disorder, creating individual treatment approaches, and conducting long-term studies to determine the most suitable time for intervention, in doing so patients' outcomes will be improved.


References 

  1. Pharaoh Fellow Mwale1†, Cheng‑Ta Hsieh1,2,3,4†, Ting‑Lin Yen5 , Jing‑Shiun Jan1 , Rajeev Taliyan6 , Chih‑Hao Yang1,7* and Wen‑Bin Yang7,8* (published,  January 18, 2025). Title: Chitinase-3-like-1: a multifaceted player in neuroinflammation and degenerative pathologies with therapeutic implications. Link: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-025-00801-8.pdf. 

  2. Maroua Jalouli1, Md Ataur Rahman2, Partha Biswas3, Hasanur Rahman4, Abdel Halim Harrath5, In-Seon Lee6,7, Sojin Kang8, Jinwon Choi8, Moon Nyeo Park8, Bonglee Kim8,9* (published, January 23, 2025). Title:  Targeting natural antioxidant polyphenols to protect neuroinflammation and neurodegenerative diseases: a comprehensive review. Link: https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1492517/full#B3.

  3. American Brain Foundation. (Published, January 13, 2025). Title: Neuroinflammation: What Many Brain Diseases Have in Common. Link: https://www.americanbrainfoundation.org/what-is-neuroinflammation/#:~:text=Neuroinflammation%20is%20a%20crucial%20underlying,to%20age%2C%E2%80%9D%20explains%20Dr. 

  4. Paras Mani Giri, Anurag Banerjee, Arpita Ghosal and Buddhadev Layek (Published, April 3, 2024). Title: Neuroinflammation in Neurodegenerative Disorders: Current Knowledge and Therapeutic Implications. Link: https://www.mdpi.com/1422-0067/25/7/3995 

  5. Jéssica Silva dos Santos1*, João Pedro Gonçalves Cirino2, Patrícia de Oliveira Carvalho2, Manoela Marques Ortega  (Published, January 12, 2021). Title: The Pharmacological Action of Kaempferol in Central Nervous System Diseases: A Review. Link: https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2020.565700/full.

  6. Elodie Kip, Louise C. Parr-Brownlie (Published, June 2022) Title: Reducing neuroinflammation via therapeutic compounds and lifestyle to prevent or delay progression of Parkinson’s disease. Link: https://www.sciencedirect.com/science/article/pii/S1568163722000605. 

  7. Gao, C., Jiang, J., Tan, Y. et al. Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Sig Transduct Target Ther 8, 359 (Published, September 22, 2023). Link: https://doi.org/10.1038/s41392-023-01588-0.

  8. Socodato, Renato*; Relvas, João B.*. Neuroinflammation revisited through the microglial lens. Neural Regeneration Research 20(7):p 1989-1990, July 2025. | DOI: 10.4103/NRR.NRR-D-24-00284. Link: https://journals.lww.com/nrronline/fulltext/2025/07000/neuroinflammation_revisited_through_the_microglial.12.aspx 

 
 
 

Comments

bottom of page